{"id":3102,"date":"2021-12-27T08:39:14","date_gmt":"2021-12-27T08:39:14","guid":{"rendered":"https:\/\/aceoncology.org\/?p=3102"},"modified":"2021-12-27T08:39:15","modified_gmt":"2021-12-27T08:39:15","slug":"dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas","status":"publish","type":"post","link":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/","title":{"rendered":"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027"},"content":{"rendered":"\n<p>\u8111\u80f6\u8d28\u7624\u662f\u6210\u4eba\u539f\u53d1\u6027\u8111\u80bf\u7624\u4e2d\u6700\u5e38\u89c1\u7684\u7c7b\u578b\u3002\u5c3d\u7ba1\u5728\u7406\u89e3\u8fd9\u4e9b\u80bf\u7624\u7684\u5206\u5b50\u53d1\u75c5\u673a\u5236\u548c\u751f\u7269\u5b66\u65b9\u9762\u53d6\u5f97\u4e86\u91cd\u8981\u8fdb\u5c55\uff0c\u4f46\u8fd9\u4e9b\u8fdb\u5c55\u5e76\u6ca1\u6709\u8f6c\u5316\u4e3a\u60a3\u8005\u6cbb\u7597\u6216\u9884\u540e\u7684\u663e\u8457\u6539\u5584\u3002\u4e34\u5e8a\u8fdb\u5c55\u7f3a\u4e4f\u7684\u53ef\u80fd\u539f\u56e0\u5305\u62ec\u80f6\u8d28\u7624\u76f8\u5bf9\u7f55\u89c1\u3001\u8bbe\u8ba1\u7a7f\u8fc7\u8840\u8111\u5c4f\u969c\u7684\u6cbb\u7597\u836f\u7269\u7684\u6311\u6218\u548c\u80bf\u7624\u5f02\u8d28\u6027\u3002\u7cbe\u51c6\u533b\u5b66\u4e2d\u80f6\u8d28\u7624\u6cbb\u7597\u9776\u70b9\u7684\u786e\u5b9a\u5b58\u5728\u5de8\u5927\u7684\u672a\u6ee1\u8db3\u9700\u6c42\u3002BRAF V600\u7a81\u53d8\u53c2\u4e0e\u6fc0\u6d3b\u591a\u79cd\u80bf\u7624\u7c7b\u578b\u7684MAPK\u901a\u8def\uff0c\u5305\u62ec\u9ad8\u8fbe15%\u7684\u4f4e\u7ea7\u522b\u80f6\u8d28\u7624\u548c3%\u7684\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624\u3002BRAF\u6291\u5236\u5242\u8fbe\u62c9\u975e\u5c3c\u548cMEK\u6291\u5236\u5242\u66f2\u7f8e\u66ff\u5c3c\u5bf9MAPK\u901a\u8def\u7684\u53cc\u91cd\u963b\u65ad\u5df2\u5728BRAF V600E\u7a81\u53d8\u7684\u9ed1\u8272\u7d20\u7624\u3001\u7532\u72b6\u817a\u672a\u5206\u5316\u764c\u548c\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u4e2d\u8bc1\u660e\u4e86\u5176\u5177\u6709\u4e34\u5e8a\u610f\u4e49\u7684\u7597\u6548\uff0c\u662f\u643a\u5e26\u8be5\u7a81\u53d8\u60a3\u8005\u7684\u6807\u51c6\u6cbb\u7597\u3002\u4e00\u9879\u591a\u961f\u5217\u591a\u4e2d\u5fc3\u3001\u5355\u7ec4\u3001II\u671f\u7bee\u5b50\u8bd5\u9a8c\u2014\u2014\u7f55\u89c1\u80bf\u7624\u63a2\u7d22\u7814\u7a76\uff08ROAR\uff09\u8bd5\u9a8c\u4e2d\uff0c\u8bc4\u4ef7\u4e86\u8be5\u8054\u5408\u6cbb\u7597\u5728\u643a\u5e26BRAF V600E\u7a81\u53d8\u7684\u7f55\u89c1\u80bf\u7624\u60a3\u8005\u4e2d\u7684\u6d3b\u6027\u548c\u5b89\u5168\u6027\u3002<\/p>\n\n\n\n<p>\u8fd1\u671f\uff0c<a href=\"https:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(21)00578-7\/fulltext\">ROAR\u8bd5\u9a8c\u4e2d<\/a>\u590d\u53d1\u6027\/\u96be\u6cbb\u6027BRAF V600E\u7a81\u53d8\u578b\u4f4e\u548c\u9ad8\u7ea7\u522b\u80f6\u8d28\u7624\u60a3\u8005\u7684\u9884\u5148\u8ba1\u5212\u7684\u4e2d\u671f\u5206\u6790\u7ed3\u679c\u53d1\u5e03\u3002\u57284\u5e74\u671f\u95f4\uff0c\u7814\u7a76\u8005\u5728\u9ad8\u7ea7\u522b\u961f\u5217\u4e2d\u5165\u7ec4\u4e8645\u4f8b\u60a3\u8005\uff0c\u5176\u4e2d\u5305\u62ec31\u4f8b\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624\u60a3\u8005\uff0c\u5728\u4f4e\u7ea7\u522b\u80f6\u8d28\u7624\u961f\u5217\u4e2d\u5165\u7ec4\u4e8613\u4f8b\u60a3\u8005\u3002\u7814\u7a76\u7684\u4e3b\u8981\u7ec8\u70b9\u662f\u7814\u7a76\u8005\u6839\u636e\u795e\u7ecf\u80bf\u7624\u5b66\u7f13\u89e3\u8bc4\u4f30\uff08RANO\uff09\u6807\u51c6\u8bc4\u4f30\u7684\u5ba2\u89c2\u7f13\u89e3\u7387\uff08ORR\uff09\u3002\u9ad8\u7ea7\u522b\u7ec4\u7684\u4e2d\u4f4d\u968f\u8bbf\u65f6\u95f4\u4e3a12.7\u4e2a\u6708\uff0c\u4f4e\u7ea7\u522b\u961f\u5217\u7684\u4e2d\u4f4d\u968f\u8bbf\u65f6\u95f4\u4e3a32.2\u4e2a\u6708\u3002\u9ad8\u7ea7\u522b\u961f\u5217\u4e2d15\u4f8b\u60a3\u8005\uff0833%\uff09\u8fbe\u5230\u5ba2\u89c2\u7f13\u89e3\uff0c\u5305\u62ec3\u4f8b\u5b8c\u5168\u7f13\u89e3\uff08CR\uff09\u3002\u5728\u4f4e\u5206\u7ea7\u961f\u5217\u4e2d\uff0c9\u4f8b\u60a3\u8005\uff0869%\uff09\u8fbe\u5230\u5ba2\u89c2\u7f13\u89e3\uff0c\u5305\u62ec1\u4f8bCR\u3002\u72ec\u7acb\u653e\u5c04\u5b66\u5ba1\u67e5\u8bc1\u5b9e\u4e86\u8fd9\u4e9b\u7ed3\u679c\uff0c\u786e\u5b9a31%\u7684\u9ad8\u7ea7\u522b\u961f\u5217\u548c69%\u7684\u4f4e\u7ea7\u522b\u961f\u5217\u8fbe\u5230\u5ba2\u89c2\u7f13\u89e3\u3002\u6839\u636e\u72ec\u7acb\u653e\u5c04\u5ba1\u67e5\u7ed3\u679c\uff0c\u9ad8\u7ea7\u522b\u548c\u4f4e\u7ea7\u522b\u80f6\u8d28\u7624\u7684\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\u5206\u522b\u4e3a13.6\u4e2a\u6708\u548c27.5\u4e2a\u6708\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u63a5\u53d7\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u6cbb\u7597\u7684\u9ad8\u7ea7\u522b\u80f6\u8d28\u7624\u60a3\u8005\u7684\u603b\u751f\u5b58\u671f\uff08OS\uff09\u4e3a17.6\u4e2a\u6708\uff08\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624\u4e3a13.6\u4e2a\u6708\uff09\uff0c\u662f\u65e2\u5f80\u63a5\u53d7\u8fc7\u6cbb\u7597\u7684\u590d\u53d1\u6027\/\u96be\u6cbb\u6027\u75be\u75c5\u60a3\u8005\u5316\u7597\u6240\u62a5\u544aOS\u7684\u4e24\u500d\u591a\u3002\u4e00\u534a\u60a3\u8005\u53d1\u751f3\u7ea7\u6216\u4ee5\u4e0a\u4e0d\u826f\u4e8b\u4ef6\uff1b\u6700\u5e38\u89c1\u7684\u662f\u75b2\u4e4f\uff089%\uff09\u3001\u4e2d\u6027\u7c92\u7ec6\u80de\u8ba1\u6570\u4e0b\u964d\uff089%\uff09\u3001\u5934\u75db\uff085%\uff09\u548c\u4e2d\u6027\u7c92\u7ec6\u80de\u51cf\u5c11\u75c7\uff085%\uff09\u3002\u4e24\u4e2a\u961f\u5217\u4e2d\u5747\u672a\u53d1\u751f\u6cbb\u7597\u76f8\u5173\u6b7b\u4ea1\u3002\u603b\u4f53\u800c\u8a00\uff0c\u5b89\u5168\u6027\u7279\u5f81\u4e0e\u5176\u4ed6\u80bf\u7624\u7c7b\u578b\u4e2d\u89c2\u5bdf\u5230\u7684\u7ed3\u679c\u4e00\u81f4\u3002<\/p>\n\n\n\n<p>\u7ed3\u679c\u8868\u660e\uff0c\u8fbe\u62c9\u975e\u5c3c + \u66f2\u7f8e\u66ff\u5c3c\u5728\u643a\u5e26BRAF V600E\u7a81\u53d8\u7684\u590d\u53d1\u6027\u80f6\u8d28\u7624\u60a3\u8005\u4e2d\u663e\u793a\u4e86\u663e\u8457\u7684\u7f13\u89e3\u7387\u548c\u6301\u4e45\u7684\u4e34\u5e8a\u83b7\u76ca\uff0c\u4f5c\u8005\u6307\u51fa\uff0c\u8be5\u7814\u7a76\u9996\u6b21\u663e\u793a\u4e86\u9776\u5411\u6cbb\u7597\u5bf9\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624\u7684\u6709\u4e34\u5e8a\u610f\u4e49\u7684\u6d3b\u6027\u3002\u4ed6\u4eec\u8ba4\u4e3a\u8fd9\u4e9b\u7ed3\u679c\u9700\u8981\u5728\u76f8\u540c\u7684\u7814\u7a76\u4eba\u7fa4\u4ee5\u53ca\u643a\u5e26BRAF V600E\u7a81\u53d8\u7684\u521d\u6cbb\u60a3\u8005\u4e2d\u8fdb\u4e00\u6b65\u7814\u7a76\u8be5\u836f\u7269\u65b9\u6848\u3002\u6b64\u5916\uff0c\u4ed6\u4eec\u5efa\u8bae\u4e34\u5e8a\u533b\u751f\u5236\u5b9a\u80f6\u8d28\u7624\u6cbb\u7597\u7b56\u7565\u65f6\uff0c\u7eb3\u5165\u5305\u62ecBRAF V600E\u7a81\u53d8\u7684\u5206\u5b50\u7b5b\u67e5\u7b56\u7565\uff0c\u4ee5\u786e\u5b9a\u53ef\u80fd\u4ece\u8be5\u6cbb\u7597\u7ec4\u5408\u4e2d\u83b7\u76ca\u7684\u60a3\u8005\u3002\u675c\u514b\u764c\u75c7\u4e2d\u5fc3\u7684Katherine B. Peters\u535a\u58eb<a href=\"https:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(21)00662-8\/fulltext\">\u70b9\u8bc4\u4e86\u8fd9\u9879\u7814\u7a76<\/a>\uff0c\u4ed6\u8868\u660e\u8fd9\u9879\u7814\u7a76\u201c\u4ee3\u8868\u4e86\u4e00\u79cd\u6cbb\u7597\u683c\u5c40\u7684\u8f6c\u53d8\uff0c\u5c06\u7ecf\u8fc7\u4ed4\u7ec6\u8003\u91cf\u628a\u9776\u5411\u7597\u6cd5\u6574\u5408\u5230\u80f6\u8d28\u7624\u60a3\u8005\u7684\u6cbb\u7597\u4e2d\u3002\u201d<strong><\/strong><\/p>\n\n\n\n<p><strong>\u53c2\u8003\u6587\u732e\uff1a<\/strong><br>Wen PY et al. <em>Lancet Oncol<\/em>. 2021 Nov 24. [Online ahead of print].<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u8111\u80f6\u8d28\u7624\u662f\u6210\u4eba\u539f\u53d1\u6027\u8111\u80bf\u7624\u4e2d\u6700\u5e38\u89c1\u7684\u7c7b\u578b\u3002\u5c3d\u7ba1\u5728\u7406\u89e3\u8fd9\u4e9b\u80bf\u7624\u7684\u5206\u5b50\u53d1\u75c5\u673a\u5236\u548c\u751f\u7269\u5b66\u65b9\u9762\u53d6\u5f97\u4e86\u91cd\u8981\u8fdb\u5c55\uff0c\u4f46\u8fd9\u4e9b\u8fdb [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":3021,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-3102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027 - ACE Oncology<\/title>\n<meta name=\"description\" content=\"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u662f\u9996\u4e2a\u88ab\u8bc1\u5b9e\u5bf9\u4e8eBRAF\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u6709\u6548\u7684\u9776\u5411\u6cbb\u7597\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027 - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u662f\u9996\u4e2a\u88ab\u8bc1\u5b9e\u5bf9\u4e8eBRAF\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u6709\u6548\u7684\u9776\u5411\u6cbb\u7597\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-27T08:39:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-27T08:39:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/12\/Untitled-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"451\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ACE Demo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ACE Demo\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/\"},\"author\":{\"name\":\"ACE Demo\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\"},\"headline\":\"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027\",\"datePublished\":\"2021-12-27T08:39:14+00:00\",\"dateModified\":\"2021-12-27T08:39:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/\"},\"wordCount\":48,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/12\/Untitled-2.png\",\"articleSection\":[\"\u6587\u7ae0\u7cbe\u8981\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/\",\"name\":\"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027 - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/12\/Untitled-2.png\",\"datePublished\":\"2021-12-27T08:39:14+00:00\",\"dateModified\":\"2021-12-27T08:39:15+00:00\",\"description\":\"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u662f\u9996\u4e2a\u88ab\u8bc1\u5b9e\u5bf9\u4e8eBRAF\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u6709\u6548\u7684\u9776\u5411\u6cbb\u7597\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/12\/Untitled-2.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/12\/Untitled-2.png\",\"width\":451,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\",\"name\":\"ACE Demo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"caption\":\"ACE Demo\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027 - ACE Oncology","description":"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u662f\u9996\u4e2a\u88ab\u8bc1\u5b9e\u5bf9\u4e8eBRAF\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u6709\u6548\u7684\u9776\u5411\u6cbb\u7597","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/","og_locale":"zh_CN","og_type":"article","og_title":"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027 - ACE Oncology","og_description":"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u662f\u9996\u4e2a\u88ab\u8bc1\u5b9e\u5bf9\u4e8eBRAF\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u6709\u6548\u7684\u9776\u5411\u6cbb\u7597","og_url":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/","og_site_name":"ACE Oncology","article_published_time":"2021-12-27T08:39:14+00:00","article_modified_time":"2021-12-27T08:39:15+00:00","og_image":[{"width":451,"height":300,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/12\/Untitled-2.png","type":"image\/png"}],"author":"ACE Demo","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"ACE Demo","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/"},"author":{"name":"ACE Demo","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0"},"headline":"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027","datePublished":"2021-12-27T08:39:14+00:00","dateModified":"2021-12-27T08:39:15+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/"},"wordCount":48,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/12\/Untitled-2.png","articleSection":["\u6587\u7ae0\u7cbe\u8981"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/","url":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/","name":"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027 - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/12\/Untitled-2.png","datePublished":"2021-12-27T08:39:14+00:00","dateModified":"2021-12-27T08:39:15+00:00","description":"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u662f\u9996\u4e2a\u88ab\u8bc1\u5b9e\u5bf9\u4e8eBRAF\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u6709\u6548\u7684\u9776\u5411\u6cbb\u7597","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/12\/Untitled-2.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/12\/Untitled-2.png","width":451,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/dabrafenib-trametinib-combo-active-in-braf-mutant-gliomas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u8fbe\u62c9\u975e\u5c3c\/\u66f2\u7f8e\u66ff\u5c3c\u7ec4\u5408\u5728BRAF-\u7a81\u53d8\u578b\u795e\u7ecf\u80f6\u8d28\u7624\u4e2d\u5c55\u73b0\u51fa\u826f\u597d\u6d3b\u6027"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0","name":"ACE Demo","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","caption":"ACE Demo"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=3102"}],"version-history":[{"count":1,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3102\/revisions"}],"predecessor-version":[{"id":3103,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3102\/revisions\/3103"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/3021"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=3102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=3102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=3102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}